iconstar paper   HBV Articles  
Back grey arrow rt.gif
HBV Meeting Paris: Dose-Dependent Durability of Hepatitis B Surface Antigen Reductions Following Administration of a Single Dose of VIR-3434, an Investigational, Neutralizing Vaccinal Monoclonal Antibody
  International HBV Meeting; September 18-22, 2022; Paris, France
Kosh Agarwal,1 Man-Fung Yuen,2 Heiner Wedemeyer,3 Daniel Cloutier,4 Ling Shen,4 Andre Arizpe,4 Sneha V. Gupta,4 Marie Fanget,4 Lillian Seu,4 Andrea L. Cathcart,4 Audrey H. Lau,4 Carey Hwang,4 Edward Gane5
1Institute of Liver Studies, King’s College Hospital, London, United Kingdom; 2Queen Mary Hospital, The University of Hong Kong, Hong Kong, China; 3Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany; 4Vir Biotechnology, Inc., San Francisco, CA, USA;
5Faculty of Medicine, University of Auckland, Auckland, New Zealand







  iconpaperstack View Older Articles   Back to Top   www.natap.org